Ohtani M, Kobayashi S, Miyamoto A, Hayashi K, Fukui Y
The University Farm, Obihiro University of Agriculture and Veterinary Medicine, Japan.
Biol Reprod. 1998 Jan;58(1):103-8. doi: 10.1095/biolreprod58.1.103.
Recent observations suggest that the endothelial cell-derived vasoconstrictive peptide endothelin-1 (ET-1) interacts with prostaglandin F2alpha (PGF2alpha) and that luteal ET-1 participates in the rapid cascade of functional luteolysis in vivo. Thus, the present study aimed to determine in detail the real-time changes in ET-1, oxytocin (OT), and progesterone (P4) concentrations within the regressing corpus luteum (CL), along with the changes in ovarian venous plasma (OVP) ipsilateral to the CL as well as in jugular venous plasma (JVP) in the cow. In the first study, peripheral plasma from daily sampling during the estrous cycle (n = 6) showed clear changes in ET-1 concentration with the stage of the cycle (p < 0.05). ET-1 remained at basal concentrations (23.2+/-1.3 pg/ml) on Days 2-12, increased (p < 0.05) on Days 13-19 (33.5+/-2.6 pg/ml), and reached the highest (p < 0.001) concentrations (45.6+/-4.4 pg/ml) on Days 20-22 after estrus. These data indicate that plasma ET-1 concentration increases around luteolysis and estrus. In the second study, a microdialysis system (MDS) was surgically implanted into the CL of 11 cows in the midluteal phase. In 4 of the 11 cows, the catheter was also fitted to the ovarian vein ipsilateral to the CL at surgery. A PGF2alpha analogue (cloprostenol; 500 microg) was then injected (designated as 0 h) i.m. to induce luteolysis. In the cows fitted with an MDS, the PGF2alpha injection clearly induced a rapid decrease in intraluteal P4 release within 4 h (p < 0.05), and the levels decreased to 20% of the baseline after 24 h. Intraluteal release of ET-1 increased (p < 0.05) to 160% within 4 h after PGF2alpha injection, when an enormous OT release (to 950%) occurred, which reached a plateau of 250% after 20 h that persisted until 72 h. ET-1 release into the ovarian vein began to increase at 2 h after PGF2alpha injection, when the acute OT release almost dropped to the baseline. The ET-1 concentration was temporarily (between 0 and 24 h after PGF2alpha) 2-3 times higher in OVP than in JVP (p < 0.05), and increased again to higher levels than in JVP from 32 to 64 h (p < 0.05). ET-1 concentrations in JVP gradually increased from 10 pg/ml to 30 pg/ml during PGF2alpha-induced luteolysis (p < 0.05). In conclusion, PGF2alpha injection rapidly increased ET-1 release within the regressing CL as well as into the ovarian venous blood in the cow. The overall results strongly support the hypothesis that luteal ET-1 is a local luteolytic mediator/promotor in the regressing bovine CL.
最近的观察结果表明,内皮细胞衍生的血管收缩肽内皮素 -1(ET-1)与前列腺素F2α(PGF2α)相互作用,并且黄体ET-1参与体内功能性黄体溶解的快速级联反应。因此,本研究旨在详细确定退化黄体(CL)内ET-1、催产素(OT)和孕酮(P4)浓度的实时变化,以及与CL同侧的卵巢静脉血浆(OVP)和奶牛颈静脉血浆(JVP)的变化。在第一项研究中,发情周期期间每日采样的外周血浆(n = 6)显示ET-1浓度随周期阶段有明显变化(p < 0.05)。ET-1在第2 - 12天保持在基础浓度(23.2±1.3 pg/ml),在第13 - 19天升高(p < 0.05)(33.5±2.6 pg/ml),并在发情后第20 - 22天达到最高(p < 0.001)浓度(45.6±4.4 pg/ml)。这些数据表明血浆ET-1浓度在黄体溶解和发情前后升高。在第二项研究中,将微透析系统(MDS)手术植入11头处于黄体中期的奶牛的CL中。在11头奶牛中的4头,导管在手术时也安装到与CL同侧的卵巢静脉。然后肌肉注射PGF2α类似物(氯前列醇;500μg)(指定为0小时)以诱导黄体溶解。在安装了MDS的奶牛中,PGF2α注射在4小时内明显诱导黄体P4释放迅速下降(p < 0.05),并且在24小时后水平降至基线的20%。PGF2α注射后4小时内,黄体ET-1释放增加(p < 0.05)至160%,此时发生大量OT释放(至950%),在20小时后达到250%的平台期并持续至72小时。PGF2α注射后2小时,ET-1释放到卵巢静脉开始增加,此时急性OT释放几乎降至基线。在PGF2α注射后0至24小时内,OVP中的ET-1浓度暂时比JVP高2至3倍(p < 0.05),并在32至64小时再次升高至高于JVP的水平(p < 0.05)。在PGF2α诱导的黄体溶解过程中,JVP中的ET-1浓度从10 pg/ml逐渐增加到30 pg/ml(p < 0.05)。总之,PGF2α注射迅速增加了退化CL内以及奶牛卵巢静脉血中的ET-1释放。总体结果有力地支持了黄体ET-1是退化牛CL中的局部黄体溶解介质/促进剂这一假设。